x

Search for a clinical trial

* (*) mandatory field

EORTC 62961: Phase III randomized study of neoadjuvant Etoposide, Ifosfamide, and Doxorubicin with or without regional hyperthermia in patients with high-risk soft tissue sarcoma - DE

  • Type of clinical trial : Drug clinical trial
  • Recruiting project : No
  • Status : Terminated trial
  • Funding body(ies) :
  • Geographic coverage : National
  • Sponsor : Eortc
    • Phase : III
  • Principal investigator of clinical trial

  • Pr Rolf D. ISSELS
  • Medizinische Klinik und Poliklinik III
  • LMU Klinikum der Universität München - Campus Großhadern
  • Marchioninistraße 15
  • 81377 MÜNCHEN
  • GERMANY
  • More information
  • Phone  : 49 (0)89 4400 72551
  • Fax  : 49 (0)89 4400 75550
  • Website
  • Contact secretary  :
  • Sponsor of clinical trial

  • EORTC
  • European Organisation for the Research and Treatment of Cancer
  • EORTC
  • Avenue Mounierlaan 83/11
  • 1200 BRUSSELS
  • BELGIUM
  • More information
  • Phone  : 0032 2 7741611
  • Fax  : 0032 2 7723545
  • Website
Last update: September 2015

Additional information

The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.